Teclistamab (BCMAxCD3) Journey from Discovery to Filing
Time: 9:30 am
day: Day Two
Details:
- Telling the story of a BCMA-targeted drug developmental success from bench to bedside
- Exploring the latest exciting data and predicting gaps and future directions for space
